Not Medicare Enrolled

Dr. Van Rana, 09221980

Medical Oncology · Fort Myers, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3840 BROADWAY, Fort Myers, FL 33901
2392756400
In practice since 2006 (19 years)
NPI: 1881770659 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rana from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rana? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rana

Dr. Van Rana is a medical oncology specialist in Fort Myers, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rana performed 75,835 Medicare services across 3,005 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rana received a total of $8,242 from 76 pharmaceutical and/or device companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rana is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 29% volume in FL $8,242 industry payments

Medicare Practice Summary

Medicare Utilization ↗
75,835
Medicare services
Top 29% in FL for medical oncology
3,005
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,991 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
17,850 $0 $4
Azacitidine chemotherapy injection
An injection of the medication azacitidine, measured at 1 mg per unit.
17,100 $0 $4
Filgrastim injection (Zarxio) for white blood cells
An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram.
9,240 $0 $2
Pembrolizumab injection (Keytruda) 8,400 $43 $137
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
6,090 $6 $23
Iron sucrose injection (Venofer)
An injection of iron sucrose used to replenish iron levels in the body.
4,500 $0 $5
Denosumab injection (Prolia/Xgeva) 2,580 $18 $51
Anti-nausea injection (aprepitant) 1,690 $1 $5
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
1,640 $36 $108
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
1,333 $8 $29
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,293 $8 $9
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
854 $0 $3
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
612 $99 $339
Anti-nausea injection (Aloxi/palonosetron) 450 $1 $28
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
443 $11 $69
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
170 $104 $378
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
156 $12 $61
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
144 $18 $59
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
128 $51 $189
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
113 $57 $206
Anti-nausea injection (ondansetron/Zofran) 112 $0 $9
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
112 $1 $6
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
109 $67 $239
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
83 $2 $7
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
70 $10 $42
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
69 $1 $3
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
67 $25 $156
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
56 $23 $84
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
47 $16 $56
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
47 $22 $79
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
42 $4 $15
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
32 $129 $453
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
30 $52 $178
Methylprednisolone injection, up to 40 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg.
29 $3 $11
Venipuncture for blood collection
A procedure to draw blood from a vein for medical testing or analysis.
27 $69 $277
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
24 $24 $89
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
23 $30 $156
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
21 $136 $467
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
18 $137 $474
Automated red blood cell count
An automated laboratory test that measures the number of red blood cells in a blood sample.
16 $4 $10
New patient office visit, complex (60-74 min) 15 $173 $585
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.5% high complexity
68.6% medium
4.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,242
Total received (2018-2024)
Avg $1,177/year across 7 years
Top 48% in FL for medical oncology
76
Companies
437
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,780 (94.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$462 (5.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$32
2023
$1,597
2022
$1,770
2021
$1,100
2020
$1,202
2019
$1,310
2018
$1,232

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$600
Janssen Biotech, Inc.
$461
Celgene Corporation
$446
GENZYME CORPORATION
$441
Exelixis Inc.
$389
Amgen Inc.
$386
Spectrum Pharmaceuticals Inc.
$372
Merck Sharp & Dohme Corporation
$369
Astellas Pharma US Inc
$353
Novartis Pharmaceuticals Corporation
$344
Lilly USA, LLC
$343
Merck Sharp & Dohme LLC
$337
Incyte Corporation
$293
Genentech USA, Inc.
$276
PFIZER INC.
$193
Pharmacyclics LLC, An AbbVie Company
$187
Gilead Sciences, Inc.
$181
AstraZeneca Pharmaceuticals LP
$159
Daiichi Sankyo Inc.
$142
Regeneron Healthcare Solutions, Inc.
$135
Seagen Inc.
$121
ARRAY BIOPHARMA INC
$113
Medtronic MiniMed, Inc.
$78
Puma Biotechnology, Inc.
$75
BeiGene USA, Inc.
$74
CTI BioPharma Corp.
$69
Takeda Pharmaceuticals U.S.A., Inc.
$58
Kite Pharma, Inc.
$57
Deciphera Pharmaceuticals Inc.
$51
EMD Serono, Inc.
$50
PharmaEssentia USA Corporation
$48
Acrotech Biopharma LLC
$46
Sun Pharmaceutical Industries Inc.
$40
MorphoSys, US Inc.
$40
CSL Behring
$38
Helsinn Therapeutics (U.S.), Inc.
$38
ABBVIE INC.
$38
NanoString Technologies, Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$36
Rigel Pharmaceuticals, Inc.
$35
TerSera Therapeutics LLC
$33
SOBI, INC
$31
Alnylam Pharmaceuticals Inc.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Secura Bio, Inc.
$31
JAZZ PHARMACEUTICALS INC.
$30
Agios Pharmaceuticals, Inc.
$28
Dendreon Pharmaceuticals LLC
$25
Jazz Pharmaceuticals Inc.
$23
Pharmacyclics LLC, an AbbVie Company
$23
AbbVie, Inc.
$23
EISAI INC.
$23
AbbVie Inc.
$22
Catalyst Pharmaceuticals, Inc.
$22
Emmaus Medical, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Kyowa Kirin, Inc.
$19
Epizyme, Inc.,
$18
Stemline Therapeutics Inc.
$18
Eisai Inc.
$18
Sobi, Inc
$18
Acceleron Pharma, Inc.
$17
AVEO Pharmaceuticals, Inc.
$17
TESARO, Inc.
$16
Aveo Pharmaceuticals, Inc.
$15
Sumitomo Pharma America, Inc.
$13
Alexion Pharmaceuticals, Inc.
$13
Myovant Sciences Inc.
$12
Blueprint Medicines Corporation
$11
Sysmex America, Inc.
$11
Partner Therapeutics, Inc.
$11
GE HEALTHCARE
$9
Fortovia Therapeutics, Inc.
$9
Janssen Pharmaceuticals, Inc
$4
Veracyte, Inc.
$1
Top 3 companies account for 18.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · AYVAKIT · Abraxane · Alecensa · Avastin · BELEODAQ · BESREMI · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CERDELGA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Endari · Enhertu · Erleada · FARYDAK · FIRDAPSE · FOTIVDA · Farydak · Folotyn · GAZYVA · GILOTRIF · HEMADY · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LUMAKRAS · LYNPARZA · Lenvima · Leukine · MONJUVI · MVASI · Minimed 670G System · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Reblozyl · Revlimid · SANDOSTATIN · SARCLISA · SCEMBLIX · SUTENT · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TUKYSA · Tavalisse · Trodelvy · VENCLEXTA · VERZENIO · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XN Series · XOSPATA · XTANDI · YONSA · YONSA (abiraterone acetate) · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zuplenz
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $11 per 100 Medicare services performed
Looking for a medical oncology specialist in Fort Myers?
Compare medical oncologists in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
11
Per 100K population
1.4
County median income
$73,099
Nearest hospital
LEE MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rana is a mixed practice specialist, with above-average Medicare volume (top 29% in FL), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rana experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Rana performed 17,850 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rana receive payments from pharmaceutical companies?
Yes. Dr. Rana received a total of $8,242 from 76 companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rana's costs compare to other medical oncologists in Fort Myers?
Dr. Rana's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rana) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →